NCT05316259View on ClinicalTrials.gov

A Food-Effect Study of BPI-16350 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
Healthy
Interventions
DRUG

BPI-16350

Administered orally

Trial Locations (1)

100069

Kthics Committee (seal),of Beijing Youan Hospital,Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Betta Pharmaceuticals Co., Ltd.

INDUSTRY